PAX6 and type 2 diabetes mellitus: Noticeably, transduction of T2D islets with AAV‐PAX6 (STZ/T2D‐PAX6) prior to transplantation further lowered the blood glucose level, indicating enhanced glycemic control by the transplanted islets in vivo.